{"nct_id":"NCT04003610","title":"Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205)","status":"TERMINATED","status_verified_date":"2022-05","start_date":"2020-05-14","start_date_type":"ACTUAL","primary_completion_date":"2021-04-18","primary_completion_date_type":"ACTUAL","completion_date":"2021-04-18","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["INCY"]}